Fundación Pública Galega de Medicina Xenómica
Research center
Publications by the researcher in collaboration with Anxo Vidal Figueroa (10)
2022
-
Silver Clusters of Five Atoms as Highly Selective Antitumoral Agents Through Irreversible Oxidation of Thiols
Advanced Functional Materials, Vol. 32, Núm. 29
2013
-
Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 330-337
2008
-
Highly efficient system to deliver taxanes into tumor cells: Docetaxel-loaded chitosan oligomer colloidal carriers
Biomacromolecules, Vol. 9, Núm. 8, pp. 2186-2193
-
Hypochondroplasia and acanthosis nigricans: A new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?
European Journal of Endocrinology, Vol. 159, Núm. 3, pp. 243-249
1999
-
Complex regulation of prothymosin alpha in mammary tumors arising in transgenic mice
Life Sciences, Vol. 64, Núm. 23, pp. 2125-2133
1998
-
Overexpression of prothymosin α accelerates proliferation and retards differentiation in HL-60 cells
Biochemical Journal, Vol. 331, Núm. 3, pp. 753-761
-
Prothymosin α stimulates Ca2+-dependent phosphorylation of elongation factor 2 in cellular extracts
Journal of Biological Chemistry, Vol. 273, Núm. 17, pp. 10147-10152
-
TGF-β1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth
Oncogene, Vol. 16, Núm. 11, pp. 1455-1465
1997
-
Development of ELISA to estimate thymosin α1, the N terminus of prothymosin α, in human tumors
Clinical Chemistry, Vol. 43, Núm. 1, pp. 59-63
1995
-
Regulation of thymosin β4 mRNA levels during cell proliferation
Cell Proliferation, Vol. 28, Núm. 2, pp. 85-91